Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
30 Leser
Artikel bewerten:
(0)

Blood Collection and Processing Supplies - Global Strategic Business Report 2016 - Blood Conservation Takes Center Stage - Research and Markets

DUBLIN, April 21, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Blood Collection and Processing Supplies - Global Strategic Business Report" report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO )

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

This report analyzes the worldwide markets for Blood Collection and Processing Supplies in US$ by the following Product Segments:

  • Blood Administration Sets
  • Blood Collection Needles
  • Blood Collection Tubes & Micro Collectors
  • Blood Lancets
  • Blood Bags
  • Blood Grouping Reagents
  • Coagulation Reagents
  • Hematology Reagents
  • Microscopic Slides
  • Slide Stainers
  • Test Tube Racks
  • Vials

The report profiles 121 companies including many key and niche players such as

  • AdvaCare Pharmaceuticals (China)
  • Beckman Coulter, Inc. (US)
  • Becton, Dickinson and Company (US)
  • Fresenius Kabi AG (Germany)
  • Fenwal, Inc. (US)
  • Grifols International S.A. (Spain)
  • Haemonetics Corporation (US)
  • Immucor, Inc. (US)
  • JMS Co. Ltd. (Japan)
  • Kawasumi Laboratories, Inc. (Japan)
  • MacoPharma SA (France)
  • Shanghai Transfusion Technology Co., Ltd. (China)
  • Stago (France)
  • Terumo Corporation (Japan)
  • Terumo BCT, Inc. (US)

Key Topics Covered:

1. Industry Overview

2. Market Dynamics

3. Competitive Landscape In The Blood Processing Supplies And Equipment Market

4. Blood Collection Market

5. Blood Components & Derivatives

6. Blood Banking

7. Autologous Blood Transfusions Vis-A-Vis Allogenic Blood Transfusions

8. Autologous Transfusions: Minimizing Risk Of Blood-Borne Diseases

9. Blood Collection And Processing Supplies: An Overview

10. Product Innovations/Introductions

11. Recent Industry Activity

12. Focus On Select Players

13. Global Market Perspective

Total Companies Profiled: 121 (including Divisions/Subsidiaries 134)

  • The United States (44)
  • Canada (3)
  • Japan (5)
  • Europe (47)
  • - France (3)
  • - Germany (11)
  • - The United Kingdom (12)
  • - Italy (4)
  • - Spain (1)
  • - Rest of Europe (16)
  • Asia-Pacific (Excluding Japan) (28)
  • Latin America (1)
  • Africa (4)
  • Middle-East (2)

For more information visit http://www.researchandmarkets.com/research/stfp9p/blood_collection

Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.